2019 annual financial data
Intellia Therapeutics 2019 Operating cash flow margin
Direct answer
Operating cash flow margin was -239.52%.
Operating income was -106,368,000 USD and net income was -99,533,000 USD.
Operating cash flow was -103,240,000 USD.
Get free Intellia Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 43,103,000 USD
- Operating income
- -106,368,000 USD
- Net income
- -99,533,000 USD
- Operating cash flow
- -103,240,000 USD